Medivir Ser (MVRBF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 3 7 sessions, January 11, 2022 to February 1, 2023
- Largest daily move
- +20.6% close of February 1, 2023
- 1-year change
- -21.2% closing prices, January 11, 2022 to February 1, 2023
Company Description
Medivir Ser (OTC: MVRBF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $45.8M.
MVRBF has declined 21.2% over the past year. The last closing price was $0.8200.
This page collects what Stock Titan holds for MVRBF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Medivir Ser (MVRBF) closed at $0.8200 on February 1, 2023. Over the past 12 months, the price has lost 21.2%.
MVRBF Metrics & Rankings
Price returns through February 1, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Medivir Ser has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, conferences, management. View all MVRBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MVRBF Company Profile & Sector Positioning
Medivir Ser (MVRBF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MVRBF often look at related companies in the same sector, including CalciMedica, Inc. (CALC), Tempest Therapeutics, Inc. (TPST), Verrica Pharmaceuticals Inc. (VRCA), PLUS THERAPEUTICS, Inc. (PSTV), and Annovis Bio, Inc. (ANVS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MVRBF's relative position within its industry.